Olink Holding AB (publ) (NASDAQ:OLK) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Olink Holding AB (publ) (NASDAQ:OLK) announced its quarterly earnings results on Wednesday. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.07, Briefing.com reports. Olink Holding AB (publ) had a negative return on equity of 4.05% and a negative net margin of 11.72%. The firm had revenue of $44.15 million for the quarter, compared to analysts’ expectations of $42.62 million.

Olink Holding AB (publ) Trading Up 0.1 %

Shares of OLK traded up $0.02 during trading hours on Friday, reaching $25.85. 1,009,204 shares of the company traded hands, compared to its average volume of 518,897. Olink Holding AB has a 12 month low of $14.10 and a 12 month high of $26.47. The company has a quick ratio of 5.84, a current ratio of 7.41 and a debt-to-equity ratio of 0.01. The company’s fifty day moving average price is $19.52 and its two-hundred day moving average price is $18.95. The company has a market capitalization of $3.21 billion, a price-to-earnings ratio of -184.49 and a beta of 0.60.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Morgan Stanley upped their target price on Olink Holding AB (publ) from $18.00 to $26.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 24th. Leerink Partnrs cut Olink Holding AB (publ) from an “outperform” rating to a “market perform” rating in a research note on Tuesday, October 17th. Finally, Scotiabank reissued a “sector perform” rating on shares of Olink Holding AB (publ) in a research note on Wednesday, October 18th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $24.75.

Hedge Funds Weigh In On Olink Holding AB (publ)

A number of institutional investors have recently bought and sold shares of the stock. Raymond James & Associates bought a new position in shares of Olink Holding AB (publ) in the 1st quarter worth about $209,000. Clearbridge Investments LLC increased its stake in shares of Olink Holding AB (publ) by 0.8% in the 1st quarter. Clearbridge Investments LLC now owns 1,448,029 shares of the company’s stock worth $25,572,000 after acquiring an additional 11,655 shares in the last quarter. UBS Group AG increased its holdings in shares of Olink Holding AB (publ) by 174.3% during the first quarter. UBS Group AG now owns 7,071 shares of the company’s stock valued at $125,000 after acquiring an additional 4,493 shares in the last quarter. Gilder Gagnon Howe & Co. LLC increased its holdings in shares of Olink Holding AB (publ) by 45.1% during the first quarter. Gilder Gagnon Howe & Co. LLC now owns 74,307 shares of the company’s stock valued at $1,312,000 after acquiring an additional 23,080 shares in the last quarter. Finally, Capital International Investors increased its holdings in shares of Olink Holding AB (publ) by 19.7% during the first quarter. Capital International Investors now owns 1,409,527 shares of the company’s stock valued at $24,892,000 after acquiring an additional 232,371 shares in the last quarter. 32.25% of the stock is owned by institutional investors.

Olink Holding AB (publ) Company Profile

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.